“I don’t want to talk about a victory lap over a very unfortunate, very malignant disease,” Ross began. “But the fact is, it does give business yet another thing to consider when they go through their review of their supply chain. It’s another risk factor that people need to take into account. So I think it will help to accelerate the return of jobs to North America.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.